Aehr Test Systems (NASDAQ: AEHR)’s stock price has dropped by -1.57 in relation to previous closing price of 11.15. Nevertheless, the company has seen a loss of -7.23% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-10 that Investors need to pay close attention to Aehr Test Systems (AEHR) stock based on the movements in the options market lately.
Is It Worth Investing in Aehr Test Systems (NASDAQ: AEHR) Right Now?
Aehr Test Systems (NASDAQ: AEHR) has a higher price-to-earnings ratio of 21.19x compared to its average ratio. AEHR has 36-month beta value of 1.99. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AEHR is 27.10M, and currently, short sellers hold a 20.70% ratio of that float. The average trading volume of AEHR on April 18, 2024 was 1.41M shares.
AEHR’s Market Performance
AEHR stock saw a decrease of -7.23% in the past week, with a monthly decline of -23.57% and a quarterly a decrease of -35.89%. The volatility ratio for the week is 5.08%, and the volatility levels for the last 30 days are 6.39% for Aehr Test Systems (AEHR). The simple moving average for the past 20 days is -9.81% for AEHR’s stock, with a -62.96% simple moving average for the past 200 days.
Analysts’ Opinion of AEHR
Many brokerage firms have already submitted their reports for AEHR stocks, with Craig Hallum repeating the rating for AEHR by listing it as a “Hold.” The predicted price for AEHR in the upcoming period, according to Craig Hallum is $12 based on the research report published on March 26, 2024 of the current year 2024.
AEHR Trading at -25.27% from the 50-Day Moving Average
After a stumble in the market that brought AEHR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.71% of loss for the given period.
Volatility was left at 6.39%, however, over the last 30 days, the volatility rate increased by 5.08%, as shares sank -26.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.86% lower at present.
During the last 5 trading sessions, AEHR fell by -7.02%, which changed the moving average for the period of 200-days by -75.14% in comparison to the 20-day moving average, which settled at $11.97. In addition, Aehr Test Systems saw -58.63% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AEHR starting from Erickson Gayn, who sale 4,871 shares at the price of $17.39 back on Jan 18 ’24. After this action, Erickson Gayn now owns 427,935 shares of Aehr Test Systems, valued at $84,726 using the latest closing price.
ROGERS VERNON, the Exec VP of Sales & Mktg. of Aehr Test Systems, sale 1,309 shares at $17.39 during a trade that took place back on Jan 18 ’24, which means that ROGERS VERNON is holding 40,277 shares at $22,769 based on the most recent closing price.
Stock Fundamentals for AEHR
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.49 for the gross margin
The net margin for Aehr Test Systems stands at 0.21. The total capital return value is set at 0.14. Equity return is now at value 19.86, with 16.56 for asset returns.
Based on Aehr Test Systems (AEHR), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at 1.01. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is -27.28.
Currently, EBITDA for the company is 13.38 million with net debt to EBITDA at -2.91. When we switch over and look at the enterprise to sales, we see a ratio of 3.82. The receivables turnover for the company is 12.37for trailing twelve months and the total asset turnover is 0.71. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.06.
Conclusion
To put it simply, Aehr Test Systems (AEHR) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
